Our finding suggested that CSF antibody titer indices warrant further evaluation as a prognostic factor in LGI1 autoimmunity. A higher antibody titer might indicate the need for more aggressive initial immunotherapy. This evidence concerns the gene LGI1 and Autoimmunity.